Anti-apoptotic mechanisms of HIV: Lessons and novel approaches to curing HIV

Cellular and Molecular Life Sciences

Volumn 70, Issue 18, 2013, Pages 3355-3363

  Cummins, Nathan W ^a   Badley, Andrew D ^a  

^a MAYO CLINIC   (United States)

Author keywords

Apoptosis; Human immunodeficiency virus; Immune evasion; Latency

Indexed keywords

CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; ENFUVIRTIDE; FLICE INHIBITORY PROTEIN; HISTONE DEACETYLASE; MITOGEN ACTIVATED PROTEIN KINASE; NEF PROTEIN; PROTEIN BAD; PROTEINASE INHIBITOR; REACTIVE OXYGEN METABOLITE; RNA DIRECTED DNA POLYMERASE; STRUCTURAL PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VIF PROTEIN; VPR PROTEIN; X LINKED INHIBITOR OF APOPTOSIS;

ANTIVIRAL ACTIVITY; APOPTOSIS; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CELL CYCLE ARREST; CELL DIFFERENTIATION; CYTOPATHOGENIC EFFECT; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE EVASION; LATENT VIRUS INFECTION; NONHUMAN; REVIEW; VIRUS LATENCY; VIRUS REACTIVATION; VIRUS REPLICATION;

ANIMALS; ANTI-HIV AGENTS; APOPTOSIS; CYTOPATHOGENIC EFFECT, VIRAL; DNA MUTATIONAL ANALYSIS; HIV; HIV INFECTIONS; HUMANS; MYELOID CELLS; VIRUS LATENCY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 84883454797     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-012-1239-3     Document Type: Review

References (74)

1. Galluzzi L, Vitale I, Abrams JM et al (2012) Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on cell death 2012. Cell Death Differ 19:107-120
2. Cummins NW, Badley AD (2010) Mechanisms of HIV-associated lymphocyte apoptosis. Cell Death Dis 1:e99
3. Fevrier M, Dorgham K, Rebollo A (2011) CD4+ T cell depletion in human immunodeficiency virus (HIV) infection: role of apoptosis. Viruses 3:586-612
4. Aillet F, Masutani H, Elbim C et al (1998) Human immunodeficiency virus induces a dual regulation of Bcl-2, resulting in persistent infection of CD4(+) T- or monocytic cell lines. J Virol 72:9698-9705
5. Olivares I, Ballester A, Lombardia L, Dominguez O, Lopez-Galindez C (2009) Human immunodeficiency virus type 1 chronic infection is associated with different gene expression in MT-4, H9 and U937 cell lines. Virus Res 139:22-31
6. Wang X, Viswanath R, Zhao J, Tang S, Hewlett I (2010) Changes in the level of apoptosis-related proteins in Jurkat cells infected with HIV-1 versus HIV-2. Mol Cell Biochem 337:175-183
7. Bren GD, Trushin SA, Whitman J, Shepard B, Badley AD (2009) HIV gp120 induces, NF-kappaB dependent, HIV replication that requires procaspase 8. PLoS ONE 4:e4875
8. Bren GD, Whitman J, Cummins N et al (2008) Infected cell killing by HIV-1 protease promotes NF-kappaB dependent HIV-1 replication. PLoS ONE 3:e2112
9. Cummins N, Badley A (2009) The TRAIL to viral pathogenesis: the good, the bad and the ugly. Curr Mol Med 9:495-505
10. Broker LE, Kruyt FA, Giaccone G (2005) Cell death independent of caspases: a review. Clin Cancer Res 11:3155-3162
11. Hotchkiss RS, Strasser A, McDunn JE, Swanson PE (2009) Cell death. N Engl J Med 361:1570-1583
12. Wei X, Ghosh SK, Taylor ME et al (1995) Viral dynamics in human immunodeficiency virus type 1 infection. Nature 373:117-122
13. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M (1995) Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123-126
14. Dimitrov DS, Willey RL, Sato H, Chang LJ, Blumenthal R, Martin MA (1993) Quantitation of human immunodeficiency virus type 1 infection kinetics. J Virol 67:2182-2190
15. Conti L, Rainaldi G, Matarrese P et al (1998) The HIV-1 vpr protein acts as a negative regulator of apoptosis in a human lymphoblastoid T cell line: possible implications for the pathogenesis of AIDS. J Exp Med 187:403-413
16. Conti L, Matarrese P, Varano B et al (2000) Dual role of the HIV-1 vpr protein in the modulation of the apoptotic response of T cells. J Immunol 165:3293-3300
17. Wang J, Shackelford JM, Selliah N et al (2008) The HIV-1 Vif protein mediates degradation of Vpr and reduces Vpr-induced cell cycle arrest. DNA Cell Biol 27:267-277
18. Wildum S, Schindler M, Munch J, Kirchhoff F (2006) Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection. J Virol 80:8047-8059
19. Greenway AL, McPhee DA, Allen K et al (2002) Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis. J Virol 76:2692-2702
20. Castedo M, Ferri KF, Blanco J et al (2001) Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation. J Exp Med 194:1097-1110
21. Giroud C, Chazal N, Briant L (2011) Cellular kinases incorporated into HIV-1 particles: passive or active passengers? Retrovirology 8:71
22. Bukong TN, Hall WW, Jacque JM (2010) Lentivirus-associated MAPK/ERK2 phosphorylates EMD and regulates infectivity. J Gen Virol 91:2381-2392
23. Kohno M, Tanimura S, Ozaki K (2011) Targeting the extracellular signal-regulated kinase pathway in cancer therapy. Biol Pharm Bull 34:1781-1784
24. Doitsh G, Cavrois M, Lassen KG et al (2010) Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 143:789-801
25. Keedy KS, Archin NM, Gates AT, Espeseth A, Hazuda DJ, Margolis DM (2009) A limited group of class I histone deacetylases acts to repress human immunodeficiency virus type 1 expression. J Virol 83:4749-4756
26. Sanna MG, da Silva Correia J, Ducrey O et al (2002) IAP suppression of apoptosis involves distinct mechanisms: the TAK1/JNK1 signaling cascade and caspase inhibition. Mol Cell Biol 22:1754-1766
27. Berro R, de la Fuente C, Klase Z et al (2007) Identifying the membrane proteome of HIV-1 latently infected cells. J Biol Chem 282:8207-8218
28. Kim CH, Chiplunkar S, Gupta S (2004) Chronic HIV type 1 infection down-regulates expression of DAP kinase and p19ARF-p53 checkpoint and is associated with resistance to CD95-mediated apoptosis in HUT78 T cells. AIDS Res Hum Retroviruses 20:183-189
29. Gibellini D, Caputo A, Celeghini C et al (1995) Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection. Br J Haematol 89:24-33
30. Gibellini D, Re MC, Ponti C et al (2001) HIV-1 Tat protects CD4+ Jurkat T lymphoblastoid cells from apoptosis mediated by TNF-related apoptosis-inducing ligand. Cell Immunol 207:89-99
31. Zauli G, Gibellini D, Caputo A et al (1995) The human immunodeficiency virus type-1 Tat protein upregulates Bcl-2 gene expression in Jurkat T-cell lines and primary peripheral blood mononuclear cells. Blood 86:3823-3834
32. Wang Z, Morris GF, Reed JC, Kelly GD, Morris CB (1999) Activation of Bcl-2 promoter-directed gene expression by the human immunodeficiency virus type-1 Tat protein. Virology 257:502-510
33. Col E, Caron C, Chable-Bessia C et al (2005) HIV-1 Tat targets Tip60 to impair the apoptotic cell response to genotoxic stresses. EMBO J 24:2634-2645
34. Gibellini D, Re MC, Ponti C et al (2005) HIV-1 Tat protein concomitantly down-regulates apical caspase-10 and up-regulates c-FLIP in lymphoid T cells: a potential molecular mechanism to escape TRAIL cytotoxicity. J Cell Physiol 203:547-556
35. Badley AD, Parato K, Cameron DW et al (1999) Dynamic correlation of apoptosis and immune activation during treatment of HIV infection. Cell Death Differ 6:420-432
36. Yue FY, Kovacs CM, Dimayuga RC et al (2005) Preferential apoptosis of HIV-1-specific CD4+ T cells. J Immunol 174:2196-2204
37. Zhu Y, Roshal M, Li F, Blackett J, Planelles V (2003) Upregulation of survivin by HIV-1 Vpr. Apoptosis 8:71-79
38. Altieri DC (2010) Survivin and IAP proteins in cell-death mechanisms. Biochem J 430:199-205
39. Mishra S, Mishra JP, Kumar A (2007) Activation of JNK-dependent pathway is required for HIV viral protein R-induced apoptosis in human monocytic cells: involvement of antiapoptotic BCL2 and c-IAP1 genes. J Biol Chem 282:4288-4300
40. Cohen I, Boya P, Zhao L et al (2004) Anti-apoptotic activity of the glutathione peroxidase homologue encoded by HIV-1. Apoptosis 9:181-192
41. Wolf D, Witte V, Laffert B et al (2001) HIV-1 Nef associated PAK and PI3-kinases stimulate Akt-independent Bad-phosphorylation to induce anti-apoptotic signals. Nat Med 7:1217-1224
42. DeLuca C, Kwon H, Pelletier N, Wainberg MA, Hiscott J (1998) NF-kappaB protects HIV-1-infected myeloid cells from apoptosis. Virology 244:27-38
43. Tanaka Y, Kameoka M, Ota K, Itaya A, Ikuta K, Yoshihara K (1999) Establishment of persistent infection with HIV-1 abrogates the caspase-3-dependent apoptotic signaling pathway in U937 cells. Exp Cell Res 247:514-524
44. Fernandez Larrosa PN, Croci DO, Riva DA et al (2008) Apoptosis resistance in HIV-1 persistently-infected cells is independent of active viral replication and involves modulation of the apoptotic mitochondrial pathway. Retrovirology 5:19
45. Giri MS, Nebozyhn M, Raymond A et al (2009) Circulating monocytes in HIV-1-infected viremic subjects exhibit an antiapoptosis gene signature and virus- and host-mediated apoptosis resistance. J Immunol 182:4459-4470
46. Guillemard E, Jacquemot C, Aillet F, Schmitt N, Barre-Sinoussi F, Israel N (2004) Human immunodeficiency virus 1 favors the persistence of infection by activating macrophages through TNF. Virology 329:371-380
47. Olivetta E, Federico M (2006) HIV-1 Nef protects human-monocyte-derived macrophages from HIV-1-induced apoptosis. Exp Cell Res 312:890-900
48. Noursadeghi M, Tsang J, Miller RF et al (2009) Genome-wide innate immune responses in HIV-1-infected macrophages are preserved despite attenuation of the NF-kappa B activation pathway. J Immunol 182:319-328
49. Iannello A, Debbeche O, Samarani S, Ahmad A (2008) cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS. J Leukoc Biol 84:1-26
50. Bashirova AA, Thomas R, Carrington M (2011) HLA/KIR restraint of HIV: surviving the fittest. Annu Rev Immunol 29:295-317
51. Bonaparte MI, Barker E (2004) Killing of human immunodeficiency virus-infected primary T-cell blasts by autologous natural killer cells is dependent on the ability of the virus to alter the expression of major histocompatibility complex class I molecules. Blood 104:2087-2094
52. Sobieszczyk ME, Lingappa JR, McElrath MJ (2011) Host genetic polymorphisms associated with innate immune factors and HIV-1. Curr Opin HIV AIDS 6:427-434
53. Soria A, Guerini FR, Bandera A et al (2011) KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy. PLoS One 6:e27349
54. Pelak K, Need AC, Fellay J et al (2011) Copy number variation of KIR genes influences HIV-1 control. PLoS Biol 9:e1001208
55. Wonderlich ER, Leonard JA, Collins KL (2011) HIV immune evasion disruption of antigen presentation by the HIV Nef protein. Adv Virus Res 80:103-127
56. Alter G, Heckerman D, Schneidewind A et al (2011) HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 476:96-100
57. Mahlknecht U, Deng C, Lu MC et al (2000) Resistance to apoptosis in HIV-infected CD4+ T lymphocytes is mediated by macrophages: role for Nef and immune activation in viral persistence. J Immunol 165:6437-6446
58. Yoon K, Jeong JG, Kim S (2001) Stable expression of human immunodeficiency virus type 1 Nef confers resistance against Fas-mediated apoptosis. AIDS Res Hum Retroviruses 17:99-104
59. Geleziunas R, Xu W, Takeda K, Ichijo H, Greene WC (2001) HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell. Nature 410:834-838
60. Zheng L, Yang Y, Guocai L, Pauza CD, Salvato MS (2007) HIV Tat protein increases Bcl-2 expression in monocytes which inhibits monocyte apoptosis induced by tumor necrosis factor-alpha-related apoptosis-induced ligand. Intervirology 50:224-228
61. Swingler S, Mann AM, Zhou J, Swingler C, Stevenson M (2007) Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein. PLoS Pathog 3:1281-1290
62. Melki MT, Saidi H, Dufour A, Olivo-Marin JC, Gougeon ML (2010) Escape of HIV-1-infected dendritic cells from TRAIL-mediated NK cell cytotoxicity during NK-DC cross-talk - a pivotal role of HMGB1. PLoS Pathog 6:e1000862
63. Chehimi J, Papasavvas E, Tomescu C et al (2010) Inability of plasmacytoid dendritic cells to directly lyse HIV-infected autologous CD4+ T cells despite induction of tumor necrosis factor-related apoptosis-inducing ligand. J Virol 84:2762-2773
64. Schnepple DJ, Shepard B, Bren GD et al (2011) Isolation of a TRAIL antagonist from the serum of HIV-infected patients. J Biol Chem 286:35742-35754
65. Rizza SA, Badley AD (2008) HIV protease inhibitors impact on apoptosis. Med Chem 4:75-79
66. Garg H, Joshi A, Blumenthal R (2009) Altered bystander apoptosis induction and pathogenesis of enfuvirtide-resistant HIV type 1 Env mutants. AIDS Res Hum Retroviruses 25:811-817
67. Natesampillai S, Nie Z, Cummins NW et al (2010) Patients with discordant responses to antiretroviral therapy have impaired killing of HIV-infected T cells. PLoS Pathog 6:e1001213
68. Durand CM, Blankson JN, Siliciano RF (2012) Developing strategies for HIV-1 eradication. Trends Immunol 33(11):554-562
69. T.J. Henrich GS, J.Z. Li, S. Gallien, V. Ho, A.S. LaCasce, D.R. Kuritzkes (2012) Long-term reduction in peripheral blood HIV-1 reservoirs following reduced-intensity conditioning allogeneic stem cell transplantation in two HIV-positive individuals. XIX International AIDS Conference. Oral Abstract THAA0101
70. Deeks SG (2012) HIV: shock and kill. Nature 487:439-440
71. Archin NM, Espeseth A, Parker D, Cheema M, Hazuda D, Margolis DM (2009) Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. AIDS Res Hum Retroviruses 25:207-212
72. Archin NM, Liberty AL, Kashuba AD et al (2012) Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy. Nature 487:482-485
73. Shan L, Deng K, Shroff NS et al (2012) Stimulation of HIV-1-specific cytolytic T lymphocytes facilitates elimination of latent viral reservoir after virus reactivation. Immunity 36:491-501
74. Bosque A, Famiglietti M, Weyrich AS, Goulston C, Planelles V (2011) Homeostatic proliferation fails to efficiently reactivate HIV-1 latently infected central memory CD4+ T cells. PLoS Pathog 7:e1002288